Dr. Anne De Groot CEO/CSO with Dr. Patricia Bettinger, the Scientific Director of EpiVax’s Tregitope program, will be attending the 3rd Annual Antigen-Specific Immune Tolerance Drug Development meeting in Boston, MA from February 25-27, 2020.


Annie will be speaking at 1:00PM on Wednesday February 26 during the Optimizing the Identification of Novel Targets: Evaluation of Antigen & Epitope Discovery Session.  She will be addressing Antigen Discovery for Tolerance Induction (Using Immunoinformatics).

EpiVax is happy to be offering its colleagues 10% off registration.  Use code: EPIVAX10 during registration to receive the promotional rate. We hope to see you there!

If you will be in Boston for the meeting, please stop by the session and say hello, or reach out to info@epivax.com to schedule a meeting with Annie or Patricia!